- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT01695837
Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Patients With Dyslipidemia
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
The objective of this study is to design and evaluate the feasibility and the effect on diet quality and blood lipids a new dietary counseling intervention that will be sustainable in the "real-world" settings of the current clinical practice. The intervention will be initiated by the primary care physician during the routine office visits and will use paper and web-based counseling materials. Internet based healthcare, or e-healthcare, is a consumer focused health care delivery paradigm that physicians and the healthcare system can no longer ignore. Lifestyle counseling and preventive medicine are potentially ideal areas of patient care that could be provided efficiently through this emerging venue of healthcare delivery. Internet access is near-universal for Americans under the age of 60: 90% of 18-29 year-olds, 85% of 30-49 year-olds, and 70% of 50-64 year-olds.
The aims of this study are: 1) - develop a patient self-administered, computerized version of the paper-based Rate-your-Plate dietary screening Questionnaire; 2) - create counseling materials on diet and cholesterol and build a secure, HIPAA compliant, interactive web-based counseling application that will allow patients to receive personalized counseling base on the results of the screening dietary questionnaire and the goals chosen by the patients; 3) - to test the feasibility of this intervention in the clinical settings of primary care, and evaluate its effect on lipids panel at 3 and 6 months .
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Nevada
-
Reno, Nevada, Stany Zjednoczone, 89511
- UNSOM Internal Medicine
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Eligibility required documentation of a LDL-cholesterol level of 130 mg/dL or higher within the 12 months prior to enrollment. Potential subjects were also required to have access to the Internet and an active email account. The use of lipid lowering drugs was not an exclusion, but patients taking these drugs had be on the same medication and dose for at least 3 months prior to enrollment, with no changes anticipated for the duration of the trial.
Exclusion Criteria:
- We excluded patients with poorly controlled diabetes mellitus (defined by HbA1c>9%), serum creatinine above 1.5 mg/dL, malignancy, cirrhosis, eating disorders, acute coronary syndrome in the last three months, congestive heart failure NYHA class lll and lV, ongoing warfarin therapy, uncontrolled hypo- or hyperthyroidism, ongoing weight loss, history of bariatric surgery, pregnant women, and patients who scored more than 250 (on a scale of 100 to 300) on a food frequency questionnaire administered on the day of enrollment. Patients with a history of triglycerides >400 mg/dl were also excluded, since we used the Friedewald formula [LDL-C=Total cholesterol-(TGs/5+HDL-C)] to calculate LDL-cholesterol levels.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Group A-dietary counseling month 0-6
Group A Visit #1 - Weight, height, blood pressure and pulse were measured at the beginning of the visit. During a "focused office visit" the primary care physician (PCP) reviewed the results of the fasting lipid panel and diet test with the patient; the PCP provide the patient with written educational materials and access to the counseling website. Weekly automatic emails sent to patient reminding to visit the counseling website Visit #2 - Same as visit #1. Weekly automatic emails sent to patient reminding to visit the counseling website. Visit #3 - Weight, blood pressure and pulse were measured at the beginning of the visit. During a "focused office visit" the PCP reviewed the results of the new fasting lipid panel and diet test with the patient. |
|
Inny: Group B- Dietary counseling month 3-6
Group B Visit #1: Weight, height, blood pressure and pulse were measured at the beginning of the visit. Follow up visit and lab order were scheduled for 3 months. No blood test or diet test results were reviewed with the patient. Visit #2 - Weight, blood pressure and pulse were measured at the beginning of the visit. During a "focused office visit" the PCP reviewed the results of the two fasting lipid panels ; the PCP provide the patient with written educational materials and access to the counseling website. Weekly automatic emails sent to patient reminding to visit the counseling website Visit #3 - Weight, blood pressure and pulse were measured at the beginning of the visit. During a "focused office visit" the PCP reviewed the results of the new fasting lipid panel and diet test with the patient. |
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Ramy czasowe |
---|---|
LDL-Cholesterol
Ramy czasowe: up to 6 months
|
up to 6 months
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
---|---|
Total Cholesterol
Ramy czasowe: at 3 and 6 months
|
at 3 and 6 months
|
Triglycerides
Ramy czasowe: at 3 and 6 months
|
at 3 and 6 months
|
HDL-Cholesterol
Ramy czasowe: at 3 and 6 months
|
at 3 and 6 months
|
diet score
Ramy czasowe: at 3 and 6 months
|
at 3 and 6 months
|
Współpracownicy i badacze
Sponsor
Śledczy
- Dyrektor Studium: Doina Kulick, MD, MS, University of Nevada School of Medicine
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 5P20RR016464-11/8
- 5P20RR016464 (Grant/umowa NIH USA)
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Dyslipidemia
-
Kowa Research Institute, Inc.ZakończonyDyslipidemia mieszana | Pierwotna dyslipidemiaStany Zjednoczone
-
Chong Kun Dang PharmaceuticalZakończonyDyslipidemia (typ Fredricksona Ⅱa) | Dyslipidemia (typ Fredricksona Ⅱb)Republika Korei
-
Hanlim Pharm. Co., Ltd.RekrutacyjnyDyslipidemia mieszanaRepublika Korei
-
IlDong Pharmaceutical Co LtdJeszcze nie rekrutacja
-
Arrowhead PharmaceuticalsZakończonyDyslipidemia mieszanaStany Zjednoczone, Australia, Polska, Nowa Zelandia, Kanada, Węgry
-
Provident Clinical ResearchReliant PharmaceuticalsZakończony
-
Arrowhead PharmaceuticalsAktywny, nie rekrutującyDyslipidemia mieszanaStany Zjednoczone, Australia, Kanada, Nowa Zelandia
-
Yooyoung Pharmaceutical Co., Ltd.ZakończonyDyslipidemia mieszanaRepublika Korei
-
Société des Produits Nestlé (SPN)ZakończonyPierwotna dyslipidemiaChiny
-
Provident Clinical ResearchReliant PharmaceuticalsNieznanyDyslipidemia mieszana